With semaglutide, people typically start at a low dose and increase slowly over time
Zepbound (tirzepatide) is an FDA-approved prescription medication for chronic weight management in adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or 27 kg/m or greater (overweight) with at least one weight-related comorbidity
According to evidence presented before the court, iDexis was supplying approximately 84,500 units of compounded semaglutide products each month, more than the combined sales of Ozempic and Wegovy in South Africa
Novo Nordisk reminds patients that Ozempic and Wegovy, despite having the same active ingredient, are distinct products with different indications, dosages, prescribing information and titration schedules
This method allows for higher concentrations to be administered, potentially enhancing its therapeutic effects
Instead of forcing visible change overnight, it helps skin gradually return to balance